This antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, recombinant Human MAP2 (rh MAP2; Catalog#10245-H08B; NP_006829.1; Met1-Tyr478). The IgG